Brief: Shandong Weigao Group Medical Polymer says Weigao Blood enters subscription deals
23/01/2017 14:53
Jan 23 (Reuters) - Shandong Weigao Group Medical Polymer Co
Ltd 1066.HK
* Weigao Blood and subscribers entered into subscription
agreements
* Aggregate consideration for subscription is RMB536.8
million
Source text for Eikon: ID:nHKS63hvtk
Further company coverage: 1066.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shandong Weigao Medical Polymer
See all newsChina's Weigao H1 profit falls 23% as price drops, competition hit margins
Brief: Shandong Weigao Group Medical Polymer H1 Net Income Attributable RMB 890.4 Mln
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 11.4 Million H Shares From 15 May 2026 To June 5
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 3.6 Million H Shares
Brief: Shandong Weigao Group Medical Polymer Says Unit To Establish Fund Of KRW52.965 Billion